Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized, double-blind, placebo-controlled dose escalation study of ularitide for acute kidney injury after cardiac surgery
2018-004871-11Phase 2Terminated
- Sponsor
- Cardiorentis AG
- Start
- Jul 2019
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute kidney failure (AKF) comparing Ularitide arm with Placebo arm (2 arms). Started Jul 2019; status: terminated.
02
Drugs
ularitide
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on 2018-004871-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004871-11.